When an interstate commercial operator is prescribed a non-Schedule I controlled substance, and their treating medical practitioner provides explicit written clearance stating the drug does not impair safe operating abilities, the employing transport company is legally required to accept this authorization and is absolved of regulatory liability if the substance subsequently causes an impairment-related collision.
Answer: Answer
Answer
False
The core regulatory framework dictates that motor carriers can never contract away or delegate their fundamental safety responsibilities. Even with a valid prescription and a medical practitioner's blessing, the company is still strictly liable if they permit an operator who exhibits any signs of fatigue or medication-induced impairment to get behind the wheel.
Step-by-Step Solution
Key Concept
Corporate Liability versus Medical Prescription Clearance